Literature DB >> 19875116

Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers.

Peter C Jacobs1, Mathias Prokop, Yolanda van der Graaf, Martijn J Gondrie, Kristel J Janssen, Harry J de Koning, Ivana Isgum, Rob J van Klaveren, Matthijs Oudkerk, Bram van Ginneken, Willem P Mali.   

Abstract

BACKGROUND: Coronary artery calcium (CAC) and thoracic aorta calcium (TAC) can be detected simultaneously on low-dose, non-gated computed tomography (CT) scans. CAC has been shown to predict cardiovascular (CVD) and coronary (CHD) events. A comparable association between TAC and CVD events has yet to be established, but TAC could be a more reproducible alternative to CAC in low-dose, non-gated CT. This study compared CAC and TAC as independent predictors of all-cause mortality and cardiovascular events in a population of heavy smokers using low-dose, non-gated CT.
METHODS: Within the NELSON study, a population-based lung cancer screening trial, the CT screen group consisted of 7557 heavy smokers aged 50-75 years. Using a case-cohort study design, CAC and TAC scores were calculated in a total of 958 asymptomatic subjects who were followed up for all-cause death, and CVD, CHD and non-cardiac events (stroke, aortic aneurysm, peripheral arterial occlusive disease). We used Cox proportional-hazard regression to compute hazard ratios (HRs) with adjustment for traditional cardiovascular risk factors.
RESULTS: A close association between the prevalence of TAC and increasing levels of CAC was established (p<0.001). Increasing CAC and TAC risk categories were associated with all-cause mortality (p for trend=0.01 and 0.001, respectively) and CVD events (p for trend <0.001 and 0.03, respectively). Compared with the lowest quartile (reference category), multivariate-adjusted HRs across categories of CAC were higher (all-cause mortality, HR: 9.13 for highest quartile; CVD events, HR: 4.46 for highest quartile) than of TAC scores (HR: 5.45 and HR: 2.25, respectively). However, TAC is associated with non-coronary events (HR: 4.69 for highest quartile, p for trend=0.01) and CAC was not (HR: 3.06 for highest quartile, p for trend=0.40).
CONCLUSIONS: CAC was found to be a stronger predictor than TAC of all-cause mortality and CVD events in a high-risk population of heavy smokers scored on low-dose, non-gated CT. TAC, however, is stronger associated with non-cardiac events than CAC and could prove to be a preferred marker for these events. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875116     DOI: 10.1016/j.atherosclerosis.2009.09.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  39 in total

1.  Multisite extracoronary calcification indicates increased risk of coronary heart disease and all-cause mortality: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Geoffrey H Tison; Mengye Guo; Michael J Blaha; Robyn L McClelland; Matthew A Allison; Moyses Szklo; Nathan D Wong; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir
Journal:  J Cardiovasc Comput Tomogr       Date:  2015-04-07

2.  The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Angelica Ezeigwe; Oluwaseun E Fashanu; Di Zhao; Matthew J Budoff; James D Otvos; Isac C Thomas; Samia Mora; Martin Tibuakuu; Erin D Michos
Journal:  Atherosclerosis       Date:  2019-01-24       Impact factor: 5.162

3.  Coronary artery calcium score on low-dose computed tomography for lung cancer screening.

Authors:  Teresa Arcadi; Erica Maffei; Nicola Sverzellati; Cesare Mantini; Andrea I Guaricci; Carlo Tedeschi; Chiara Martini; Ludovico La Grutta; Filippo Cademartiri
Journal:  World J Radiol       Date:  2014-06-28

Review 4.  Noninvasive imaging for assessment of calcification in chronic kidney disease.

Authors:  Cristina Karohl; Luis D'Marco Gascón; Paolo Raggi
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

5.  Calcium at the carotid siphon as an indicator of internal carotid artery stenosis.

Authors:  Nikola Gotovac; Ivana Išgum; Max A Viergever; Geert J Biessels; Josip Fajdić; Birgitta K Velthuis; Mathias Prokop
Journal:  Eur Radiol       Date:  2013-01-18       Impact factor: 5.315

6.  Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael H Criqui; Julie O Denenberg; Robyn L McClelland; Matthew A Allison; Joachim H Ix; Alan Guerci; Kevin P Cohoon; Preethi Srikanthan; Karol E Watson; Nathan D Wong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-08       Impact factor: 8.311

7.  Cardiac valve calcifications on low-dose unenhanced ungated chest computed tomography: inter-observer and inter-examination reliability, agreement and variability.

Authors:  Robbert W van Hamersvelt; Martin J Willemink; Richard A P Takx; Anouk L M Eikendal; Ricardo P J Budde; Tim Leiner; Christian P Mol; Ivana Isgum; Pim A de Jong
Journal:  Eur Radiol       Date:  2014-05-10       Impact factor: 5.315

Review 8.  Vascular calcification in diabetes: mechanisms and implications.

Authors:  Janet K Snell-Bergeon; Matthew J Budoff; John E Hokanson
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

9.  Distribution, size, shape, growth potential and extent of abdominal aortic calcified deposits predict mortality in postmenopausal women.

Authors:  Mads Nielsen; Melanie Ganz; Francois Lauze; Paola C Pettersen; Marleen de Bruijne; Thomas B Clarkson; Erik B Dam; Claus Christiansen; Morten A Karsdal
Journal:  BMC Cardiovasc Disord       Date:  2010-11-10       Impact factor: 2.298

10.  Alpha-chlorofatty Acid and coronary artery or aorta calcium scores in women with systemic lupus erythematosus. A pilot study.

Authors:  Mary A Mahieu; Camelia P Guild; Carolyn J Albert; George T Kondos; James J Carr; Daniel Edmundowicz; David A Ford; Rosalind Ramsey-Goldman
Journal:  J Rheumatol       Date:  2014-08-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.